{
  "created_at": "Fri May 28 19:42:34 +0000 2021",
  "id_str": "1398323207191597056",
  "full_text": "A pioneering new pill to treat lung cancer was approved by the FDA. The drug from Amgen targets a common mutation long considered \"undruggable.\" https://t.co/DbGrCJD8oF",
  "display_text_range": [
    0,
    168
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/DbGrCJD8oF",
        "expanded_url": "https://on.wsj.com/3ux4lNg",
        "display_url": "on.wsj.com/3ux4lNg",
        "indices": [
          145,
          168
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 31,
  "favorite_count": 96,
  "possibly_sensitive": false,
  "original_created_at": "Fri May 28 17:00:06 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "肺がんの治療薬として先駆的な新薬がFDAに承認されました。アムジェン社のこの薬は、長い間「治療不可能」とされてきた一般的な突然変異をターゲットにしています。https://t.co/DbGrCJD8oF"
    },
    {
      "locale": "zh",
      "full_text": "一种治疗肺癌的开创性新药被美国食品和药物管理局批准。安进公司的这种药物针对的是一种长期以来被认为是 \"不可药用的 \"常见突变。https://t.co/DbGrCJD8oF"
    },
    {
      "locale": "zh-Hant",
      "full_text": "一種治療肺癌的開創性新藥被美國食品和藥物管理局批准。安進公司的這種藥物針對的是一種長期以來被認爲是 \"不可藥用的 \"常見突變。https://t.co/DbGrCJD8oF"
    }
  ]
}